Mode of action of calcium antagonists which alter anthracycline resistance.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism*; D001692:Biological Transport / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002460:Cell Line; D003630:Daunorubicin / Q000378:metabolism; D004317:Doxorubicin / Q000494:pharmacology; D004351:Drug Resistance; D007941:Leukemia P388 / Q000378:metabolism; D051379:Mice; D009279:Naphthacenes / Q000378:metabolism / Q000494:pharmacology; D009543:Nifedipine / Q000031:analogs & derivatives / Q000494:pharmacology; D009568:Nitrendipine; D014700:Verapamil / Q000494:pharmacology
D000903:Antibiotics, Antineoplastic; D002121:Calcium Channel Blockers; D009279:Naphthacenes; D004317:Doxorubicin; D009568:Nitrendipine; D014700:Verapamil; D009543:Nifedipine; D003630:Daunorubicin